Page last updated: 2024-09-03

anhydroecgonine methyl ester and meperidine

anhydroecgonine methyl ester has been researched along with meperidine in 1 studies

Compound Research Comparison

Studies
(anhydroecgonine methyl ester)
Trials
(anhydroecgonine methyl ester)
Recent Studies (post-2010)
(anhydroecgonine methyl ester)
Studies
(meperidine)
Trials
(meperidine)
Recent Studies (post-2010) (meperidine)
520135,7481,228343

Protein Interaction Comparison

ProteinTaxonomyanhydroecgonine methyl ester (IC50)meperidine (IC50)
Delta-type opioid receptorMus musculus (house mouse)0.5
Kappa-type opioid receptorMus musculus (house mouse)0.5
Mu-type opioid receptorHomo sapiens (human)0.4075
Delta-type opioid receptorHomo sapiens (human)0.5
Kappa-type opioid receptorHomo sapiens (human)1.435
Mu-type opioid receptorMus musculus (house mouse)0.5
Mu-type opioid receptorCavia porcellus (domestic guinea pig)0.5
Potassium voltage-gated channel subfamily H member 2Homo sapiens (human)0.3236

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bianucci, AM; Calderone, V; Coi, A; Massarelli, I; Testai, L1

Other Studies

1 other study(ies) available for anhydroecgonine methyl ester and meperidine

ArticleYear
Identification of "toxicophoric" features for predicting drug-induced QT interval prolongation.
    European journal of medicinal chemistry, 2008, Volume: 43, Issue:11

    Topics: Amino Acid Sequence; Heart; Humans; Models, Molecular; Molecular Sequence Data; Molecular Structure; Protein Subunits; Sequence Alignment; Structure-Activity Relationship; Trans-Activators; Transcriptional Regulator ERG

2008